THOMAS DAVID HULL III - 21 Mar 2025 Form 4 Insider Report for KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU)

Role
President, CEO, Director
Signature
/s/ Donald T. Gardner III, Attorney-in-fact
Issuer symbol
KEQU
Transactions as of
21 Mar 2025
Net transactions value
-$147,229
Form type
4
Filing time
24 Mar 2025, 13:56:08 UTC
Previous filing
13 Jan 2025
Next filing
14 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KEQU Common Stock Sale $10,337 -213 -0.52% $48.53 40,916 21 Mar 2025 Direct F1
transaction KEQU Common Stock Sale $100,012 -2,200 -5.4% $45.46 38,716 24 Mar 2025 Direct F2
transaction KEQU Common Stock Sale $36,880 -800 -2.1% $46.10 37,916 24 Mar 2025 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.00 to $49.00 inclusive. The reporting person undertakes to provide Kewaunee Scientific Corporation ("Kewaunee"), any security holder of Kewaunee, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.95 inclusive. The reporting person undertakes to provide Kewaunee Scientific Corporation ("Kewaunee"), any security holder of Kewaunee, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.01 to $46.18 inclusive. The reporting person undertakes to provide Kewaunee Scientific Corporation ("Kewaunee"), any security holder of Kewaunee, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.